When it comes to investment decisions, knowledge is power. Electrovaya, a player in the Electrical Equipment & Parts industry, has been catching the eye of investors with its presence on the NASDAQ. Despite its innovative strides, the company faces some financial hurdles, like a recent earnings per share loss of 0.04. However, the stock's potential isn't entirely dimmed, as analysts have set price targets as high as 8.33, suggesting room for growth. With a market capitalization of $98.8 million, Electrovaya offers a unique proposition for those willing to navigate its challenges and seize potential opportunities. Some millennials might not be particularly interested in the electrical equipment sector, but let's take a closer look at Electrovaya's fundamentals and see how they stack up against ScanSource. We'll dive into the competitive strengths of both Electrovaya and ScanSource to understand their market positions better.
Out of tens of thousands of stocks, funds, and ETFs that trade on global exchanges each represent an individual company which you can analyze using comparative analysis. To determine which one of the two entities, such as Electrovaya or Aquestive is a better fit for your portfolio, analyzing a few basic fundamental indicators is a good first step.
Correlation Between Electrovaya and Aquestive Therapeutics
In general, Stock analysis is a method for investors and traders to make individual buying and selling decisions. Stock correlation analysis is also essential because it can help investors realize that they may not be as diversified as they think. Risk management strategies are usually required to make sure all portfolios are properly aligned against their risk tolerance level. You can consider holding Electrovaya Common together with similar or unrelated positions with a negative correlation. For example, you can also add Aquestive Therapeutics to your portfolio. If Aquestive Therapeutics is not perfectly correlated to Electrovaya Common it will diversify some of the market risks out of the positively correlated stocks in your portfolio. However, the disadvantage of this sort of hedging is that it can potentially affect your investment returns throughout market cycles. When Electrovaya Common, for example, performs excellent and delivers stable returns, the negatively correlated position you locked in as a hedge may drag your returns down.
Are you currently holding both Electrovaya Common and Aquestive Therapeutics in your portfolio? Please note if you are using this as a pair-trade strategy between Electrovaya Common and Aquestive Therapeutics, watch out for correlation discrepancy over time. Relying on the historical price correlations and assuming that it will not change may lead to short-term losses. Please check
pair correlation details between ELVA and AQST for more information.
Electrovaya Common Gross Profit
Electrovaya Common Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Electrovaya Common previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Electrovaya Common Gross Profit growth over the last 10 years. Please check Electrovaya Common's
gross profit and other
fundamental indicators for more details.
Another angle On Electrovaya Common
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Revenue Breakdown
Now, let's check Electrovaya Common revenue. Based on the latest financial disclosure, Electrovaya Common Shares reported 43.37
M of revenue.
This is 98.76% lower than that of the Electrical Equipment sector and significantly higher than that of the
Industrials industry. The revenue for all United States stocks is 99.54% higher than that of Electrovaya Common. As for ScanSource we see revenue of 3.26
B, which is much higher than that of the Industrials
| ELVA | 43.37 Million | 1.31 |
| Sector | 0.0 | 0.0 |
| SCSC | 3.26 Billion | 98.69 |
"Buy low, sell high" is a classic mantra in investing, and when comparing Electrovaya and ScanSource, it becomes crucial to assess which stock offers more upside potential. Electrovaya, with a market capitalization of $98.75 million and a high probability of bankruptcy at 91.18%, presents a risky yet potentially rewarding opportunity, especially given its Wall Street target price of $6, suggesting a significant upside from its current levels. Despite its challenges, including a loss of $4.9 million from operating activities, Electrovaya's focus on electrical equipment could appeal to investors seeking exposure to the growing demand for sustainable energy solutions. On the other hand, ScanSource might offer a more stable investment, but Electrovaya's potential for growth, albeit with higher risk, could be enticing for those with a higher risk tolerance..
Can Electrovaya Common build up on the current rise?
Electrovaya's common shares have recently seen a significant rise, marked by a variance of 20.92, indicating some volatility. This could either lead to further gains or pose certain risks. Investors are closely monitoring whether Electrovaya can maintain its upward momentum, given its innovative role in battery technology. The company's success in tapping into the growing demand for sustainable energy will be key to determining if this increase is temporary or the beginning of a lasting trend.
Currently, Electrovaya's shares exhibit above-average downside volatility, which can affect stock prices, especially in bear markets. This volatility often prompts investors to adjust their portfolios, seeking stability by diversifying their holdings as prices fluctuate.Considering Electrovaya's recent performance, where it has managed to climb over 3% despite a generally sluggish market, the stock presents an intriguing opportunity for investors. With an Analyst Overall Consensus of "Strong Buy" and a potential upside price of 7.2, there's a compelling case for those looking to capitalize on growth in the energy storage sector. The valuation market value of 2.54 suggests that the stock might be undervalued compared to its real value of 3.77, indicating room for appreciation. Investors should weigh these factors alongside their risk tolerance and investment goals, but Electrovaya's current trajectory and market positioning make it a candidate worth considering for a diversified portfolio..
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Nico Santiago is a PR Contributor to Macroaxis Editorial Board. Nico is a relatively new author here at Macroaxis and he likes to work on advertising and sponsored content and marketing for the company. Nico spends most of his time surfing when the weather is nice and he spends the rest of the year writing for various blogs and companies, as he works on his upcoming books, The Rise of the Financial Machines and Time Series Modelling with AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Nico Santiago do not own shares of Electrovaya Common Shares. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]